Dear Valued Partner,
Continuity of dialysis therapy is a responsibility we take extremely seriously.
In light of recent geopolitical developments in the Middle East and the resulting adjustments across global transportation networks, we would like to proactively share an update.
Industry-wide, certain air and sea freight routes are being re-routed or adjusted, particularly on Asia–Europe corridors. These changes may lead to extended transit times and capacity constraints in parts of the market.
At this stage, we continue to manage our supply flows in line with planned service levels. Our global supply chain and logistics teams are closely monitoring developments and coordinating with partners to anticipate and mitigate potential impacts where necessary.
As part of our structured continuity planning, we are:
- Monitoring critical product flows and inventory levels across regions,
- Securing transport capacity in advance where appropriate,
- Adjusting routing options when required,
- Maintaining regular cross-functional supply reviews.
To support effective planning, we encourage customers to place orders with sufficient advance notice where possible.
We remain committed to transparent and timely communication should the situation evolve. Your usual NIPRO contact remains available for any shipment-specific inquiries.
Our focus remains unchanged: ensuring reliable support for uninterrupted patient care.